The SHFJ is a research center dedicated to molecular and functional non-invasive imaging for clinical and preclinical research in oncology, neurology, neurodegenerative disease and psychiatry. The facility includes a nuclear medicine unit and is located in Orsay's Hospital area (near Paris).
<div class="ExternalClass0CEECC93DD5C417A9817D8E54EA099C7"><p>Molecular Imaging Research Center is a preclinical research installation created by the CEA and INSERM. This installation, consists of a group of platforms dedicated to the development of animal models pertinent to human diseases.</p></div>
NeuroSpin is a research center built to develop and validate neuroimaging using ultra-high Magnetic Field headed by Dr. Denis Le Bihan, a Member of the French Academy of Sciences. It was opened on January 1st 2007. The center is recognized as a large infrastructure, for biomedical imaging, such as the CERN in Genève. It is a shared imaging facility with unique imaging devices,. An 11.7T MRI scanner for human will be installed in 2016, one of the first in the world.
The Institute of Biomedicale Imaging take part in three projects: CATI, INUMAC project and Human Brain Project.
Toutes les faits marquants de l'I²BM
The Laboratory for Methodological Developments in Positron Emission Tomography (LDM-TEP) is a structure based within the UMR 6301 CNRS-CEA-UCBN « Imaging and Therapeutical Strategies in Cerebral and Tumoral pathologies » (ISTCT), managed by Myriam Bernaudin and is located at Cyceron, a biomedical imaging platform in Caen (France).
LDM-TEP, managed by Louisa Barré, is a unique structure whose primary mission is research at the interface between chemistry and radiochemistry and biology to exploit and enlarge the scope of PET imaging. LDM-TEP focuses on the development of radiopharmaceuticals biomarkers for preclinical and clinical research.
Three undernoted themes:
For each of these three themes and, above all the latter, our team masters the disciplines of organic and analytical chemistry as well as radiochemistry and radiopharmacy. Our varied competences in the above fields allows (after automation), the transfer of radiopharmaceuticals to internal and external structures. The valorisation and application of our specificities in these areas allows the rapid clinical evaluation of promising radiopharmaceuticals.
ResearchersLouisa Barré (CEA) HDR, Team headDanielle Debruyne (UCBN) HDRFabienne Gourand (CEA)Michel Leporrier (UCBN) HDRCécile Perrio (CNRS) HDRFranck Sobrio (CEA) HDR
Anne-Elodie Lafargue(Bourse MESR, 2013-2016)Marine Morlot (Bourse CRBN, 2014-2017)Damien Cressier (Post-doctorat)Gloria Zedda (Post-doctorat)Sébastien Schmitt (Post-doctorat)
To see, click here.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.